Clinical trial · Interventional
Effect of the Subconscious on Mohs Micrographic Surgery
NCT00374062CI-TRIAL-00015085completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this study is to determine if relaxation therapy improves patient satisfaction with Mohs micrographic surgery.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Basal Cell Carcinoma | Basal Cell Carcinoma | ONTOLOGY_EXACT | 0.90 |
| Squamous Cell Carcinoma | Squamous Cell Carcinoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| relaxation therapy 1 | Behavioral | — | UNRESOLVED |
| relaxation therapy 2 | Behavioral | — | UNRESOLVED |
| relaxation therapy 3 | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- type
- EXPERIMENTAL
- label
- I
- description
- relaxation tape 1
- interventionNames
- Behavioral: relaxation therapy 1
- type
- EXPERIMENTAL
- label
- II
- description
- relaxation tape 2
- interventionNames
- Behavioral: relaxation therapy 2
- type
- PLACEBO_COMPARATOR
- label
- III
- description
- relaxation tape 3
- interventionNames
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 25 Years
Show eligibility criteria text
Inclusion Criteria: * Age 25 and older * Subjects are undergoing micrographic Mohs surgery for facial basal and squamous cell carcinoma. * The subjects are in good health. * The subjects have willingness and the ability to understand and provide informed consent for the use of their tissue and communicate with the investigator. Exclusion Criteria: * Subjects who have wound healing problems. * Subjects who have had prior Mohs surgery. * Subjects who are smokers. * Subjects who are currently using anticoagulation therapy * Subjects who have a history of bleeding disorders. * Subjects who are unable to understand the protocol or to give informed consent * Subjects with known mental illness or other psychological conditions, such as psychotic disorders, mood disorders, anxiety disorders, cognitive disorders, depression with psychotic features, dissociative disorders. * Subjects who are taking medications that may affect healing such as prednisone, or any immunosuppressants. * Subjects who are immunocompromised. * Subjects who have Diabetes Mellitus or any other condition determined by the PI to affect healing.
References
Publications (0)
Data not yet available
No reference posted for this study.